Results 251 to 260 of about 2,851,507 (299)
Some of the next articles are maybe not open access.

Triple Therapy vs Triple Therapy in COPD

Archivos de Bronconeumología (English Edition), 2017
Peer ...
López-Campos, J. L.   +2 more
openaire   +3 more sources

Antithrombotic therapy: triple therapy or triple threat?

Hematology, 2012
Abstract Antithrombotic therapy plays an essential role in the management of some of the most common and morbid medical conditions. Triple oral antithrombotic therapy (TOAT) is defined as the administration of both therapeutic oral anticoagulation (OAC) and dual antiplatelet therapy (DAPT) to patients with indications for both treatments.
Jessica, Mega, Edward T, Carreras
openaire   +2 more sources

Is There a Role for Triple Therapy After ACS?

Current Cardiology Reports, 2022
The optimal antithrombotic strategy in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) remains the subject of controversy. In this article, we review the current evidence for the use of triple therapy in acute coronary syndrome (ACS) patients.The recently published trials of AF patients undergoing PCI have ...
Bhogal, Sukhdeep   +6 more
openaire   +4 more sources

Triple Oral Antidiabetic Therapy

Journal of Diabetes and its Complications, 1998
Our objective was to determine the efficacy of adding acarbose to the combination of metformin and a sulfonylurea in the treatment of type II diabetes mellitus. Acarbose was added to the treatment regimen of 11 type II diabetic patients who were not adequately controlled on the combination of a sulfonylurea and metformin. Glycosylated hemoglobin before
openaire   +2 more sources

Triple MEL100 Therapy in Multiple Myeloma

Transplantation Proceedings, 2009
Tandem high-dose melphalan therapy with autologous peripheral stem cell support has emerged as the standard of care for patients without prohibitive comorbidities. Mucositis and gastrointestinal side effects are the most common extrahematologic side effects.
D, Berz   +9 more
openaire   +2 more sources

Triple therapy for symptomatic patients with COPD

The Lancet, 2017
Combination therapy is almost the standard for treating chronic diseases, including chronic obstructive pulmonary disease (COPD). Until 2016, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendation for highly symptomatic COPD patients at risk of exacerbations or severe airflow limitation (GOLD D) was treatment with either long ...
Fabbri Lm, Roversi S, Beghé B.
openaire   +2 more sources

The role of triple therapy in the management of COPD

Expert Review of Clinical Pharmacology, 2020
Triple therapy in COPD is becoming increasingly important with the cumulative documentation of its ability to reduce the risk of AECOPD. However, it must be established which patients benefit most from it compared to other treatments.We critically review the literature to determine, if possible, the real role of triple therapy in the treatment of COPD.
Calzetta, Luigino   +3 more
openaire   +3 more sources

Triple therapy for adult Wilms tumor

Urology, 1987
Adult Wilms tumor is still considered a rarity. Approximately 170 adult Wilms tumors have been reported. The final diagnosis is usually established with surgery. There is no specific radiologic diagnosis of adult Wilms tumor. We report on a case of Wilms tumor in a twenty-two-year-old black man.
C J, Godec   +3 more
openaire   +2 more sources

Triple H Therapy

2015
The combination of induced hypertension, hypervolemia, and hemodilution constitutes triple H therapy is an option for preventing and treating cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Although strong clinical evidence is lacking, this therapy may be appropriate for selected cases.
openaire   +1 more source

Triple Therapy: Triple Safety or Triple Danger?

The American Journal of Cardiology, 2010
Willem, Dewilde   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy